Rani Therapeutics Holdings(RANI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

RANI Rani Therapeutics Holdings

Market Closed 08-07 16:00:00 EDT

0.7920

+0.0109

+1.40%

盘后0.7800

-0.0120-1.52%

18:53 EDT

High0.8000	Low0.7822	Vol202.06K
Open0.7849	D1 Closing0.7811	Amplitude2.28%
Mkt Cap107.92M	Tradable Cap52.98M	Total Shares136.26M
T/O160.18K	T/O Rate0.30%	Tradable Shares66.89M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"RANI","market":"US","secType":"STK","nameCN":"Rani Therapeutics Holdings","latestPrice":0.792,"timestamp":1786132800000,"preClose":0.7811,"halted":0,"volume":202062,"hourTrading":{"tag":"盘后","latestPrice":0.78,"preClose":0.792,"latestTime":"18:53 EDT","volume":4261,"amount":3378.777,"timestamp":1786143217556,"change":-0.012,"changeRate":-0.015152,"amplitude":0.025253},"delay":0,"changeRate":0.013954679298425324,"floatShares":66891000,"shares":136259511,"eps":-0.287185,"marketStatus":"Market Closed","change":0.0109,"latestTime":"08-07 16:00:00 EDT","open":0.7849,"high":0.8,"low":0.7822,"amount":160180.4880228,"amplitude":0.022788,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.287185,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1786348800000},"marketStatusCode":7,"adr":0,"listingDate":1627617600000,"exchange":"NASDAQ","adjPreClose":0.7811,"preHourTrading":{"tag":"盘前","latestPrice":0.8078,"preClose":0.7811,"latestTime":"08:58 EDT","volume":1003,"amount":810.21801389,"timestamp":1786107486021,"change":0.0267,"changeRate":0.034183,"amplitude":0.006785},"postHourTrading":{"tag":"盘后","latestPrice":0.78,"preClose":0.792,"latestTime":"18:53 EDT","volume":4261,"amount":3378.777,"timestamp":1786143217556,"change":-0.012,"changeRate":-0.015152,"amplitude":0.025253},"volumeRatio":0.27924266092380334,"impliedVol":1.674,"impliedVolPercentile":0.5737},"requestUrl":"/m/hq/s/RANI","defaultTab":"news","newsList":[{"id":"2656855532","title":"Rani Therapeutics Names Michelle Gilson to Board as Audit Committee Chair","url":"https://stock-news.laohu8.com/highlight/detail?id=2656855532","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656855532?lang=en_us&edition=fundamental","pubTime":"2026-08-04 20:01","pubTimestamp":1785844916,"startTime":"0","endTime":"0","summary":"Rani Therapeutics names Michelle Gilson to board as audit committee chairRani Therapeutics named Michelle Gilson to its board, appointing her audit committee chair.Gilson was most recently CFO of Arce","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nNDL6rsJVq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","LU0889565916.HKD","LU1934455277.USD","LU0965509283.SGD","IE00B3QW5Z07.USD","SG9999015986.USD","BK4585","LU0861579265.USD","MEDI","LU1674673691.USD","LU0289739699.SGD","BK4583","IE00BN0W2W23.USD","IE00BKPKM429.USD","IBB","IE00B3T34201.USD","LU0965509101.SGD","IE00B19Z3B42.SGD","LU1430594728.SGD","RANI","LU2112291526.USD","LU1061106388.HKD","LU2324357040.USD","SG9999014021.USD","BIB","BBH","BMED","LU0965508806.USD","SG9999014039.USD","GILD","TBXU","BCDF","IE00B64PRP62.GBP","LU1934455863.HKD","LU1057294990.SGD","LU0823416689.USD","SG9999015978.USD","IE00B19Z3581.USD","NDAQ","LU0314104364.USD","SG9999015952.SGD","LU1778281490.HKD","BK4566","LU0234570918.USD","BK4139","LU2468319806.SGD","LU0114720955.EUR","IE00BN0W2T93.GBP","TMED","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656744553","title":"Rani Therapeutics Appoints Michelle Gilson to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2656744553","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656744553?lang=en_us&edition=fundamental","pubTime":"2026-08-04 20:00","pubTimestamp":1785844809,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nTUA43ZXPC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RANI","BK4539","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655874890","title":"Canaccord Genuity Remains a Buy on Rani Therapeutics Holdings (RANI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2655874890","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655874890?lang=en_us&edition=fundamental","pubTime":"2026-07-30 19:39","pubTimestamp":1785411548,"startTime":"0","endTime":"0","summary":"In a report released today, Edward Nash from Canaccord Genuity reiterated a Buy rating on Rani Therapeutics Holdings, with a price target of $5.00....","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-remains-a-buy-on-rani-therapeutics-holdings-rani-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-remains-a-buy-on-rani-therapeutics-holdings-rani-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4007","RANI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654511160","title":"Sagimet, PNC, United Rentals, Rani, Southern Copper Insider Shake-Up","url":"https://stock-news.laohu8.com/highlight/detail?id=2654511160","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654511160?lang=en_us&edition=fundamental","pubTime":"2026-07-25 21:01","pubTimestamp":1784984465,"startTime":"0","endTime":"0","summary":"Insiders have been trading these 5 stocks: (($SGMT)), (($PNC)), (($URI)), (($RANI)) and (($SCCO)). Here is a breakdown of their recent trades and t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/sagimet-pnc-united-rentals-rani-southern-copper-insider-shake-up?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/sagimet-pnc-united-rentals-rani-southern-copper-insider-shake-up?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2023250504.SGD","COPX","IE000M9KFDE8.USD","RANI","IAT","BK4516","LU1506573853.SGD","BK4139","IE00BSNM7G36.USD","LU0314104364.USD","LU0048573561.USD","LU2463526074.USD","BK4207","BK4535","BK4211","LU0310800965.SGD","LU0320765489.SGD","BK4007","LU0170899867.USD","URI","BK4104","BK4588","LU0971096721.USD","PNC","LU1917777945.USD","LU0742534661.SGD","LU0070302665.USD","DBB","LU0251142724.SGD","SETM","LU1267930227.SGD","BK4539","SGMT","LU1363072403.SGD","BK4566","LU0314106906.USD","LU2106854487.HKD","LU0208291251.USD","BK4585","LU1974910355.USD","BK4504","LU0251131958.USD","LU0052756011.USD","LU0128525689.USD","LU2023250843.SGD","PICK","LU1721428933.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653677002","title":"Top Insider Makes Bold Move on Rani Therapeutics Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2653677002","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653677002?lang=en_us&edition=fundamental","pubTime":"2026-07-24 10:03","pubTimestamp":1784858616,"startTime":"0","endTime":"0","summary":"New insider activity at Rani Therapeutics Holdings ( ($RANI) ) has taken place on July 23, 2026. Director Mir A. Imran has increased his stake in R...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/top-insider-makes-bold-move-on-rani-therapeutics-stock-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/top-insider-makes-bold-move-on-rani-therapeutics-stock-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RANI","BK4539","BK4139","LENZ","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653773264","title":"Rani Therapeutics Director, 10% Owner Mir A. Imran Buys 36,000 Shares Worth $24,840","url":"https://stock-news.laohu8.com/highlight/detail?id=2653773264","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653773264?lang=en_us&edition=fundamental","pubTime":"2026-07-24 04:11","pubTimestamp":1784837460,"startTime":"0","endTime":"0","summary":"Rani Therapeutics director, 10% owner Mir A. Imran buys 36,000 shares worth $24,840Rani Therapeutics director Mir A Imran bought 36,000 Class A shares at $0.69, lifting his directly held stake to 2,11","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260723:nNDL7kNk5P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Rani Therapeutics Director, 10% Owner Mir A. Imran Buys 36,000 Shares Worth $24,840","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RANI","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653789364","title":"Rani Therapeutics CEO Imran Talat Acquires 35,000 Shares Worth $25,193","url":"https://stock-news.laohu8.com/highlight/detail?id=2653789364","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653789364?lang=en_us&edition=fundamental","pubTime":"2026-07-22 06:29","pubTimestamp":1784672971,"startTime":"0","endTime":"0","summary":"Rani Therapeutics CEO Imran Talat acquires 35,000 shares worth $25,193Rani Therapeutics CEO Imran Talat bought 35,000 Class A common shares in an open-market purchase.Purchase price was USD 0.72 per s","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nNDL5MTZBF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Rani Therapeutics CEO Imran Talat Acquires 35,000 Shares Worth $25,193","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","RANI","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653524586","title":"Rani Therapeutics Grants CFO Nicholas Maestas Option for 2 Million Shares at $0.7 Exercise Price","url":"https://stock-news.laohu8.com/highlight/detail?id=2653524586","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653524586?lang=en_us&edition=fundamental","pubTime":"2026-07-21 04:05","pubTimestamp":1784577926,"startTime":"0","endTime":"0","summary":"Rani Therapeutics grants CFO Nicholas Maestas option for 2 million shares at $0.7 exercise priceRani Therapeutics granted CFO Nicholas Maestas a stock option for 2 million Class A shares on July 17, 2","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260720:nNDL55rxQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","LU2210149790.SGD","BK4007","IE00BN0W2T93.GBP","BK4539","SG9999014013.SGD","BK4585","SG9999014005.SGD","BCDF","SG9999014039.USD","BK4588","RANI","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","NDAQ","IE00BGHQF748.EUR","IE00BN0W2V16.EUR","LU0314104364.USD","BK4112","SG9999014021.USD","IE00BKPKM429.USD","LU2210150020.SGD","IE00BN0W2W23.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653243009","title":"Rani Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2653243009","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653243009?lang=en_us&edition=fundamental","pubTime":"2026-07-21 04:05","pubTimestamp":1784577901,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260720:nTUA8CW3QX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","RANI","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651044687","title":"Analysts Offer Insights on Healthcare Companies: Rani Therapeutics Holdings (RANI), Urogen Pharma (URGN) and vTv Therapeutics (VTVT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2651044687","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651044687?lang=en_us&edition=fundamental","pubTime":"2026-07-16 18:50","pubTimestamp":1784199034,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Rani Therapeutics Holdings (RANI), Urogen Pharma (UR...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-rani-therapeutics-holdings-rani-urogen-pharma-urgn-and-vtv-therapeutics-vtvt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-rani-therapeutics-holdings-rani-urogen-pharma-urgn-and-vtv-therapeutics-vtvt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4588","BK4139","BK4581","LU0128526141.USD","URGN","HCSG","XBI","LU0029874061.USD","LABU","VTVT","BK4539","RANI","BK4585","BK4137","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651463104","title":"Rani Therapeutics reports initial data from RT-114 study","url":"https://stock-news.laohu8.com/highlight/detail?id=2651463104","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651463104?lang=en_us&edition=fundamental","pubTime":"2026-07-15 20:40","pubTimestamp":1784119248,"startTime":"0","endTime":"0","summary":"Rani Therapeutics (RANI) reported initial data from the ongoing Phase 1 study of RT-114, an orally administered RaniPill Capsule delivering PG-102,...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/rani-therapeutics-reports-initial-data-from-rt-114-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/rani-therapeutics-reports-initial-data-from-rt-114-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","LU1280957306.USD","IE000M9KFDE8.USD","XLP","IE00BWXC8680.SGD","BK4567","LU0096364046.USD","LU0942090050.USD","BK4007","BK4018","SG9999002232.USD","LU0320765646.SGD","LU0640476718.USD","LU1585245621.USD","RANI","BK4533","LU0868494617.USD","LU1868836914.USD","LU1868837136.USD","IE00BLSP4239.USD","LU0689626769.HKD","LU1868836591.USD","LU0061475181.USD","LU1868836757.USD","LU2552382132.HKD","IE00BKDWB100.SGD","LU2552382215.SGD","LU2242646821.SGD","UGE","SG9999014542.SGD","IE00BN8TJ469.HKD","SG9999014575.USD","LU1929549753.HKD","LENZ","FSTA","BK4504","LU1066053197.SGD","LU2129689514.USD","LU2552382058.USD","SG9999015358.SGD","LU1868837300.USD","GB00BDT5M118.USD","SG9999002224.SGD","IE00BLSP4452.SGD","LU0323591593.USD","PG","LU2097829019.USD","BK4585","LU0234572021.USD","IE00B1XK9C88.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651468384","title":"Rani Therapeutics Says Oral Rt-114 Obesity Drug Candidate Tops Matched Injection Exposure in Phase 1a Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2651468384","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651468384?lang=en_us&edition=fundamental","pubTime":"2026-07-15 20:01","pubTimestamp":1784116918,"startTime":"0","endTime":"0","summary":"Rani Therapeutics says oral RT-114 obesity drug candidate tops matched injection exposure in Phase 1a dataRani Therapeutics reported positive initial Phase 1a data for RT-114, an oral RaniPill capsule","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nNDL2VvCn2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4007","RANI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651945005","title":"Rani Therapeutics Announces Positive Initial Phase 1a Data for Rt-114 for the Treatment of Obesity, with Oral Bioavailability Exceeding Matched Subcutaneous Dosing","url":"https://stock-news.laohu8.com/highlight/detail?id=2651945005","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651945005?lang=en_us&edition=fundamental","pubTime":"2026-07-15 20:00","pubTimestamp":1784116806,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nTUA8BSZV7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RANI","BK4007","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651889468","title":"Rani Therapeutics - Phase 1a Study Expanded with Additional Cohort to Define Pharmacokinetic Relationship","url":"https://stock-news.laohu8.com/highlight/detail?id=2651889468","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651889468?lang=en_us&edition=fundamental","pubTime":"2026-07-15 20:00","pubTimestamp":1784116806,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nTUA8BSZV7:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RANI","BK4539","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651500194","title":"Rani Therapeutics - no Adverse Events Attributed to Ranipill Capsule; Treatment-related Events were Mild","url":"https://stock-news.laohu8.com/highlight/detail?id=2651500194","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651500194?lang=en_us&edition=fundamental","pubTime":"2026-07-15 20:00","pubTimestamp":1784116806,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nTUA8BSZV7:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4007","RANI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651450017","title":"Rani Therapeutics - Phase 1B Study Expected to Begin in 2026 with Data Anticipated in 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2651450017","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651450017?lang=en_us&edition=fundamental","pubTime":"2026-07-15 20:00","pubTimestamp":1784116806,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nTUA8BSZV7:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4007","RANI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650972521","title":"Rani Therapeutics Announces R&D Collaboration with Pegbio","url":"https://stock-news.laohu8.com/highlight/detail?id=2650972521","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650972521?lang=en_us&edition=fundamental","pubTime":"2026-07-10 04:58","pubTimestamp":1783630723,"startTime":"0","endTime":"0","summary":"BRIEF-Rani Therapeutics Announces R&D Collaboration With PegBioJuly 9 (Reuters)-Rani Therapeutics Holdings IncRANI.O:ANNOUNCES RESEARCH AND DEVELOPMENT COLLABORATION WITH PEGBIO TO EXPAND OBESITY PIPE","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260709:nTUABRCJ4G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4007","RANI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650974118","title":"Rani Therapeutics announces research, development collaboration with PegBio","url":"https://stock-news.laohu8.com/highlight/detail?id=2650974118","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650974118?lang=en_us&edition=fundamental","pubTime":"2026-07-10 04:15","pubTimestamp":1783628121,"startTime":"0","endTime":"0","summary":"Rani Therapeutics (RANI) announced a research and development collaboration with PegBio to explore the delivery of multiple novel candidates from P...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/rani-therapeutics-announces-research-development-collaboration-with-pegbio-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/rani-therapeutics-announces-research-development-collaboration-with-pegbio-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4139","XT","KNO","BK4539","LENZ","RANI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650974640","title":"Rani Therapeutics Partners with Pegbio to Develop Oral Obesity Drug Candidates","url":"https://stock-news.laohu8.com/highlight/detail?id=2650974640","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650974640?lang=en_us&edition=fundamental","pubTime":"2026-07-10 04:11","pubTimestamp":1783627893,"startTime":"0","endTime":"0","summary":"Rani Therapeutics partners with PegBio to develop oral obesity drug candidatesRani Therapeutics entered an R&D collaboration with PegBio to develop oral RaniPill formulations for multiple obesity and ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260709:nNDL2Yk8gq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565","BK1161","RANI","BK4007","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650974374","title":"Rani Therapeutics Announces Research and Development Collaboration with Pegbio to Expand Obesity Pipeline Across Multiple Novel Candidates","url":"https://stock-news.laohu8.com/highlight/detail?id=2650974374","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650974374?lang=en_us&edition=fundamental","pubTime":"2026-07-10 04:05","pubTimestamp":1783627501,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260709:nTUABRCJ4G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RANI","BK4007","BK4539"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ranitherapeutics.com","stockEarnings":[{"period":"1week","weight":0.0231},{"period":"1month","weight":0.1429},{"period":"3month","weight":-0.1797},{"period":"6month","weight":-0.3508},{"period":"1year","weight":0.4859},{"period":"ytd","weight":-0.4133}],"compareEarnings":[{"period":"1week","weight":0.0351},{"period":"1month","weight":0.0374},{"period":"3month","weight":0.0483},{"period":"6month","weight":0.1197},{"period":"1year","weight":0.223},{"period":"ytd","weight":0.1339}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics for patients, physicians, and healthcare systems in the United States. The company develops the RaniPill capsule, a drug-agnostic oral delivery platform to deliver a variety of drug substances, including oligonucleotides, peptides, proteins, and antibodies. Its product pipeline includes RT-102, a parathyroid hormone that is in Phase I clinical trial for the treatment of osteoporosis; RT-105, an anti-TNF-alpha antibody that is in preclinical studies to treat psoriatic arthritis; RT-110, a parathyroid hormone for the treatment of hypoparathyroidism; and RT-111, an ustekinumab biosimilar for the treatment of various inflammatory conditions. The has a collaboration agreement with ProGen Co., Ltd. for the o-development and commercialization of RT-114 to treat obesity. Rani Therapeutics Holdings, Inc. was founded in 2012 and is headquartered in San Jose, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.030292},{"month":2,"riseRate":0.8,"avgChangeRate":0.053306},{"month":3,"riseRate":0,"avgChangeRate":-0.236131},{"month":4,"riseRate":0.4,"avgChangeRate":0.191507},{"month":5,"riseRate":0.2,"avgChangeRate":-0.152617},{"month":6,"riseRate":0.2,"avgChangeRate":-0.134882},{"month":7,"riseRate":0.8,"avgChangeRate":-0.013308},{"month":8,"riseRate":0.5,"avgChangeRate":0.076841},{"month":9,"riseRate":0.2,"avgChangeRate":-0.146008},{"month":10,"riseRate":0.6,"avgChangeRate":0.658105},{"month":11,"riseRate":0.6,"avgChangeRate":0.053129},{"month":12,"riseRate":0.2,"avgChangeRate":-0.107417}],"exchange":"NASDAQ","name":"Rani Therapeutics Holdings","nameEN":"Rani Therapeutics Holdings"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Rani Therapeutics Holdings(RANI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Rani Therapeutics Holdings(RANI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Rani Therapeutics Holdings,RANI,Rani Therapeutics Holdings股票,Rani Therapeutics Holdings股票老虎,Rani Therapeutics Holdings股票老虎国际,Rani Therapeutics Holdings行情,Rani Therapeutics Holdings股票行情,Rani Therapeutics Holdings股价,Rani Therapeutics Holdings股市,Rani Therapeutics Holdings股票价格,Rani Therapeutics Holdings股票交易,Rani Therapeutics Holdings股票购买,Rani Therapeutics Holdings股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Rani Therapeutics Holdings(RANI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Rani Therapeutics Holdings(RANI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}